nach oben

Reactions Weekly

Erschienen in:

01.06.2019 | Case report

Aripiprazole

Tardive dyskinesia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 23-year-old woman developed tardive dyskinesia during treatment with aripiprazole for psychotic symptoms. …

Aguilar L, et al. Tardive dyskinesia after aripiprazole treatment that improved with tetrabenazine, clozapine, and botulinum toxin. Frontiers in Pharmacology 10: 1-5, Part 281, Mar 2019. Available from: URL: http://doi.org/10.3389/fphar.2019.00281 - Spain

Titel: Aripiprazole
Tardive dyskinesia: case report
Publikationsdatum: 01.06.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-63935-z

Betamethasone-dipropionate

Case report

Colchicine

Case report

Aripiprazole/valbenazine

Case report

Rifampicin/sitafloxacin

Case report

Panobinostat/programmed cell death-1 receptor antagonists

Case report

Nivolumab

Case report

Springer Medizin

Aripiprazole

Tardive dyskinesia: case report

Excerpt

Weitere Artikel der Ausgabe 1/2019

Betamethasone-dipropionate

Colchicine

Aripiprazole/valbenazine

Rifampicin/sitafloxacin

Panobinostat/programmed cell death-1 receptor antagonists

Nivolumab

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Betamethasone-dipropionate

Colchicine

Aripiprazole/valbenazine

Rifampicin/sitafloxacin

Panobinostat/programmed cell death-1 receptor antagonists

Nivolumab